918207.fig.002a
(a) Doxorubicin
918207.fig.002b
(b) Epirubicin
918207.fig.002c
(c) Cisplatin
918207.fig.002d
(d) Flutamide
Figure 2: Cell viability analyzed by flow cytometry using double staining with AV/PI. Schematic representation of the percentage of viable cells (VC), in initial apoptosis (EAC), in late apoptosis/necrosis (LAC/NC), and necrosis (NC) after incubation with doxorubicin (a), epirubicin (b), cisplatin (c), and flutamide (d). Data express the mean and standard deviation of three independent experiments.